Our audacious goal
IAAE seeks to credential 10,000 learners globally, and to engage 10 of the top 20 companies in each regulated health industry, by the end of 2035.
The FDA defined advanced manufacturing as “a collective term for new medical product manufacturing technologies that can improve drug quality, address shortages of medicines, and speed time-to-market.” The FDA also emphasizes the public health advantages of adopting continuous and additive manufacturing methods.
Results from this FDA-funded research increase the understanding of factors that impact a manufacturer’s decision to invest in and adopt digital technologies. Analysis of interview data from manufacturer representatives revealed areas for improvement and opportunities for enhancing manufacturing resilience.